目的 本研究旨在通过影像学资料分析、探讨上颌窦局部解剖结构的差异和相关性及其对侧壁开窗上颌窦底提升主要并发症发生的影响,为避免并发症的发生提供部分参考。方法对380名患者(男性206名,女性174名)的上颌窦影像进行锥形束CT扫描分...目的 本研究旨在通过影像学资料分析、探讨上颌窦局部解剖结构的差异和相关性及其对侧壁开窗上颌窦底提升主要并发症发生的影响,为避免并发症的发生提供部分参考。方法对380名患者(男性206名,女性174名)的上颌窦影像进行锥形束CT扫描分析,分别测量上颌窦宽度、上颌窦外侧壁与内侧壁在上颌窦底形成的角度(lateral and the medial walls with respecttothefloorofthesinus,LFM)、上颌窦外侧壁厚度、上颌窦底黏骨膜厚度、上颌窦外侧壁血管直径、剩余牙槽骨高度,并分析导致侧壁开窗上颌窦底提升并发症发生与局部解剖因素之间的相关性。结果 上颌窦宽度与LFM呈正相关,此相关性在各位点中均具有统计学意义(P<0.05)。剩余牙槽骨高度与上颌窦外侧壁厚度、血管直径与外侧壁厚度、血管直径与剩余牙槽骨高度之间呈正相关,其相关性在部分位点中具有统计学意义(P<0.05)。结论 从影像学角度出发进行研究和统计分析,发现在可能引起侧壁开窗上颌窦底提升并发症的因素中,上颌窦宽度与LFM、剩余牙槽骨高度与上颌窦外侧壁厚度、血管直径与上颌窦外侧壁厚度、血管直径与剩余牙槽骨高度具有正相关关系。展开更多
OBJECTIVE: The aim of this study was to examine the antitumor effects of Qilan preparation(芪蓝颗粒) on oral squamous cell carcinoma(OSCC) in vitro and to investigate its underlying mechanisms of action. METHODS: Cell...OBJECTIVE: The aim of this study was to examine the antitumor effects of Qilan preparation(芪蓝颗粒) on oral squamous cell carcinoma(OSCC) in vitro and to investigate its underlying mechanisms of action. METHODS: Cell proliferation, cell cycle distribution and apoptosis were examined using cell counting kit-8(CCK8) and flow cytometry(FCM). The expression of PTEN and PDCD4 were determined by western blot. Changes in miR-21 levels were quantified using Taq Man stem-loop real-time PCR. After miR-21 was transiently transfected into Tca8113 cells using Lipofectamine?3000, cell proliferation, apoptosis and miR-21 and PDCD4 expression levels were measured. RESULTS: Qilan preparation inhibited Tca8113 cell growth in a dose-and time-dependent manner by inducing apoptosis and cell cycle arrest in S-phase, decreasing miR-21 levels and increasing PTEN and PDCD4 expression. Mi R-21 overexpression reversed the Qilan preparation-induced suppression of cell proliferation and induction of apoptosis while also blocking the increase in PDCD4.CONCLUSIONS: Our study revealed, for the first time, the ability of Qilan preparation to suppress TSCC cell growth and elucidated that Qilan preparation elicits its anti-cancer actions via either the miR-21/PDCD4 or PTEN pathway.展开更多
文摘目的 本研究旨在通过影像学资料分析、探讨上颌窦局部解剖结构的差异和相关性及其对侧壁开窗上颌窦底提升主要并发症发生的影响,为避免并发症的发生提供部分参考。方法对380名患者(男性206名,女性174名)的上颌窦影像进行锥形束CT扫描分析,分别测量上颌窦宽度、上颌窦外侧壁与内侧壁在上颌窦底形成的角度(lateral and the medial walls with respecttothefloorofthesinus,LFM)、上颌窦外侧壁厚度、上颌窦底黏骨膜厚度、上颌窦外侧壁血管直径、剩余牙槽骨高度,并分析导致侧壁开窗上颌窦底提升并发症发生与局部解剖因素之间的相关性。结果 上颌窦宽度与LFM呈正相关,此相关性在各位点中均具有统计学意义(P<0.05)。剩余牙槽骨高度与上颌窦外侧壁厚度、血管直径与外侧壁厚度、血管直径与剩余牙槽骨高度之间呈正相关,其相关性在部分位点中具有统计学意义(P<0.05)。结论 从影像学角度出发进行研究和统计分析,发现在可能引起侧壁开窗上颌窦底提升并发症的因素中,上颌窦宽度与LFM、剩余牙槽骨高度与上颌窦外侧壁厚度、血管直径与上颌窦外侧壁厚度、血管直径与剩余牙槽骨高度具有正相关关系。
基金Supported by Fujian Provincial Healthy and Family Planning Commission Program:Effects of Qilan Preparation on the Expression of miRNA-21 and Its Target Proteins in Human Tongue Squamous Cell Carcinoma Cells (No. 2017-2-38)。
文摘OBJECTIVE: The aim of this study was to examine the antitumor effects of Qilan preparation(芪蓝颗粒) on oral squamous cell carcinoma(OSCC) in vitro and to investigate its underlying mechanisms of action. METHODS: Cell proliferation, cell cycle distribution and apoptosis were examined using cell counting kit-8(CCK8) and flow cytometry(FCM). The expression of PTEN and PDCD4 were determined by western blot. Changes in miR-21 levels were quantified using Taq Man stem-loop real-time PCR. After miR-21 was transiently transfected into Tca8113 cells using Lipofectamine?3000, cell proliferation, apoptosis and miR-21 and PDCD4 expression levels were measured. RESULTS: Qilan preparation inhibited Tca8113 cell growth in a dose-and time-dependent manner by inducing apoptosis and cell cycle arrest in S-phase, decreasing miR-21 levels and increasing PTEN and PDCD4 expression. Mi R-21 overexpression reversed the Qilan preparation-induced suppression of cell proliferation and induction of apoptosis while also blocking the increase in PDCD4.CONCLUSIONS: Our study revealed, for the first time, the ability of Qilan preparation to suppress TSCC cell growth and elucidated that Qilan preparation elicits its anti-cancer actions via either the miR-21/PDCD4 or PTEN pathway.
